4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kiniksa Pharmaceuticals International, plc (KNSA) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in London, United Kingdom with about 366 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, KNSA reported $678M in revenue and $59M in net income.
Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, develops and commercializes medical therapies in the United States, the United Kingdom, and internationally.
Interactive charts & full statements → Open the KNSA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $678M | $423M | $270M | $220M | — |
| Gross Profit | $370M | $362M | $237M | $197M | — |
| Operating Income (EBIT) | $77M | ($46M) | ($25M) | $10M | — |
| Net Income | $59M | ($43M) | $14M | $183M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $214M | $202M | $181M | $157M | $138M |
| Gross Profit | $118M | $111M | $97M | $86M | $76M |
| Operating Income (EBIT) | $29M | $20M | $24M | $20M | $13M |
| Net Income | $23M | $14M | $18M | $18M | $8M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $764M | $581M | $526M | $460M | — |
| Total Liabilities | $196M | $142M | $88M | $64M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KNSA viewer.
About TickerBase · Data methodology & sources